Skip to content
Contact Us
About Us Cancer Glossary A—Z Find a Treatment Center Contact Get in Touch

What Clinical Trials Are and Why They Matter

Clinical Trials

Clinical trials are carefully planned research studies that test new ways to prevent, detect, or treat cancer. These studies help doctors learn whether new treatments work better than current ones. Every cancer treatment used today was once tested in a clinical trial.

Understanding clinical trials can help patients and families make informed decisions about cancer care. These studies offer hope for better treatments while following strict safety rules to protect participants.

What Clinical Trials Test

Clinical trials test many different approaches to fighting cancer. Some studies test new drugs that target cancer cells in specific ways. Others test combinations of existing treatments to see if they work better together.

Prevention trials study ways to stop cancer from starting. These might test lifestyle changes, medicines, or vaccines. Screening trials look for better ways to find cancer early, when it is easier to treat.

Treatment trials are the most common type. They compare new treatments to standard care. Some test surgery techniques, radiation methods, or immunotherapy approaches. Research shows that testing new treatments in clinical trials is often the best way to improve cancer care according to the National Cancer Institute.

The Four Phases of Clinical Trials

Clinical trials happen in phases. Each phase answers different questions about safety and effectiveness. Phase I trials test whether a new treatment is safe. They usually include 15 to 30 people and focus on finding the right dose.

Phase II trials study whether the treatment works against specific types of cancer. These trials typically include 30 to 100 people. Researchers watch for signs that the treatment is helping while continuing to monitor safety.

Phase III trials compare the new treatment to standard care. These are larger studies with hundreds or thousands of participants. They help determine if the new treatment is better than what doctors currently use. Phase IV trials continue after a treatment is approved to watch for long-term effects.

Why Clinical Trials Matter for Progress

Clinical trials are essential for making progress against cancer. Without these studies, we would still be using the same treatments from decades ago. Every major breakthrough in cancer care came from clinical trial research.

Studies suggest that cancer survival rates have improved dramatically because of clinical trials according to the CDC. New immunotherapy treatments, targeted therapy drugs, and precision medicine approaches all started in clinical trials.

These studies also help identify treatments that do not work. This prevents patients from receiving ineffective therapies and guides researchers toward more promising approaches. The knowledge gained from each trial builds on previous research, creating a foundation for future discoveries.

Benefits and Protections for Participants

People who join clinical trials may be the first to receive new treatments that could be more effective than standard care. They receive close monitoring from research teams and often have access to the latest medical technology.

Clinical trials follow strict ethical guidelines to protect participants. Every study must be approved by an Institutional Review Board that includes doctors, researchers, and community members. This board reviews the study design to ensure the potential benefits outweigh the risks.

Participants always have the right to leave a clinical trial at any time. They receive detailed information about the study before deciding whether to join. The informed consent process ensures people understand what the trial involves, including possible side effects and time commitments.

Research shows that people in clinical trials often receive better care than those receiving standard treatment according to ClinicalTrials.gov. This may be because of the extra attention and monitoring that comes with being in a study.

How Clinical Trials Are Regulated

Multiple organizations oversee clinical trials to ensure they are conducted safely and ethically. The Food and Drug Administration regulates trials testing new drugs and medical devices. Institutional Review Boards at hospitals and research centers review each study protocol.

Data Safety Monitoring Boards review trial results regularly. These independent groups can stop a trial early if they find safety concerns or if the new treatment is clearly better than standard care. This protects participants from unnecessary risks.

Researchers must follow Good Clinical Practice guidelines. These international standards cover everything from how data is collected to how participants are informed about the study. Regular inspections ensure that trials meet these standards.

Finding and Evaluating Clinical Trials

The National Institutes of Health maintains a database of clinical trials at ClinicalTrials.gov. This site lists thousands of cancer studies happening around the world. Patients can search by cancer type, location, and other factors.

Cancer centers and oncologists can also help identify relevant trials. Many have research coordinators who specialize in matching patients with appropriate studies. Some organizations offer clinical trial matching services that consider individual medical histories.

When evaluating a clinical trial, experts suggest asking about the study’s purpose, what treatments are involved, and what side effects are possible according to the National Cancer Institute. Understanding the time commitment and travel requirements is also important for making an informed decision.

Common Myths and Misunderstandings

Myth: Clinical Trials Are Only for People Who Have Run Out of Options

This is not true. Clinical trials happen at all stages of cancer care. Some test prevention methods in healthy people. Others compare new treatments to standard care as a first-line therapy. Many trials are designed for people who are just starting treatment, not just those with advanced disease.

Myth: Participants in Clinical Trials Are Guinea Pigs

Clinical trials follow strict safety protocols and ethical guidelines. New treatments are tested extensively in laboratories before being tried in people. Participants receive careful monitoring and can leave the study at any time. The goal is always to find treatments that are safer and more effective than current options.

Myth: Placebos Are Common in Cancer Clinical Trials

Studies that compare a new treatment to a placebo (inactive substance) are rare in cancer research. Most cancer trials compare new treatments to the current standard of care. When placebos are used, they are typically combined with standard treatment, so participants still receive active cancer therapy.

Key Takeaways

  • Clinical trials are research studies that test new ways to prevent, detect, and treat cancer, following strict safety and ethical guidelines
  • Every cancer treatment used today was once tested in a clinical trial, making these studies essential for medical progress
  • Trials happen in four phases, each designed to answer specific questions about safety and effectiveness
  • Participants may benefit from access to new treatments and receive close monitoring from research teams
  • Multiple oversight organizations ensure trials are conducted safely and participants’ rights are protected
  • Clinical trials are available for people at all stages of cancer care, not just those with advanced disease

Learn More


Disclaimer: This information is for educational purposes only and is not medical advice. Talk to a healthcare provider about questions related to your health.

Share this article:

Related Posts